Vance Holly 4
4 · Neoleukin Therapeutics, Inc. · Filed Oct 20, 2020
Insider Transaction Report
Form 4
Vance Holly
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2020-10-19+220,000→ 220,000 totalExercise: $12.30Exp: 2030-10-19→ Common Stock (220,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the total shares on October 19, 2021, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.